chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test
Clinical narrative: Dizzy; Not feeling great; Extreme fatigue; Bad headaches; Heart doesn't feel as bad; A spontaneous report, was received from a consumer (patient), a 48-years-old female patient of unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced dizziness, not feeling great, really tired and pretty bad headaches.  The patient's medical history included pericarditis secondary to coronavirus. No relevant concomitant medications were reported. The patient underwent COVID-19 test which was negative on an unknown date in 2020. The patient was not sure if the vaccine triggered her present symptoms.   On 21 Jan 2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (lot number: 029L20A), intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date in Jan 2021, after administering the vaccine, the patient had dizziness, bad headaches, really tired, and not feeling great. The patient experienced similar symptoms last year when she was diagnosed with pericarditis which was caused by coronavirus. but her heart doesn't  feel bad now. The patient did not have any testing at that time; but she was negative 7 weeks later. No treatment details were provided.  Action taken with second dose of mRNA-1273 in response to the events was not reported.   The outcome of events, heart doesn't feel as bad, dizzy, not feeling great, really tired, and pretty bad headaches were not reported.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Delayed reaction to the COVID vaccination; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Delayed reaction to the COVID vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed reaction to the COVID vaccination). At the time of the report, VACCINATION COMPLICATION (Delayed reaction to the COVID vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Concomitant product use was unknown by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: No specific follow-up information recorded.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Pruritus, Vaccination site erythema, Vaccination site warmth
Clinical narrative: feeling warm; itching at injection site, injection site more itchy; Red mark on left arm, injection site redder; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (feeling warm), INJECTION SITE PRURITUS (itching at injection site, injection site more itchy), VACCINATION SITE ERYTHEMA (Red mark on left arm, injection site redder) and PRURITUS (itchy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ALLERGY RELIEF [CETIRIZINE HYDROCHLORIDE]) for Allergy, PANTOPRAZOLE, HYDROCHLOROTHIAZIDE and Artorvastatin for an unknown indication.  On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 22-Jan-2021, the patient experienced VACCINATION SITE WARMTH (feeling warm), INJECTION SITE PRURITUS (itching at injection site, injection site more itchy), VACCINATION SITE ERYTHEMA (Red mark on left arm, injection site redder) and PRURITUS (itchy).    On 22-Jan-2021, VACCINATION SITE WARMTH (feeling warm) had resolved.   On 28-Jan-2021, INJECTION SITE PRURITUS (itching at injection site, injection site more itchy), VACCINATION SITE ERYTHEMA (Red mark on left arm, injection site redder) and PRURITUS (itchy) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itching underneath the area where received the shot; the area was red; fever of 100F; read area was broken out with a rash, rash on her arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PRURITUS (itching underneath the area where received the shot), VACCINATION SITE RASH (read area was broken out with a rash, rash on her arm), VACCINATION SITE ERYTHEMA (the area was red) and PYREXIA (fever of 100F) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included Seizures in 1972. Concurrent medical conditions included Drug allergy (Avelox), Drug allergy (Codeine) and Acid reflux (esophageal). Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), EZETIMIBE and SIMVASTATIN for Cholesterol, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Rhinorrhea, TOPIRAMATE for Seizures.   On 22-Jan-2021 at 2:50 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021 at 1:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021 at 8:00 AM, the patient experienced VACCINATION SITE RASH (read area was broken out with a rash, rash on her arm). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itching underneath the area where received the shot), VACCINATION SITE ERYTHEMA (the area was red) and PYREXIA (fever of 100F). The patient was treated with HYDROCORTISONE for Rash, at a dose of 1 dosage form. On 30-Jan-2021, VACCINATION SITE RASH (read area was broken out with a rash, rash on her arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itching underneath the area where received the shot) and VACCINATION SITE ERYTHEMA (the area was red) had resolved and PYREXIA (fever of 100F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) fever of 100F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-Apr-2021 included:  Age at Vaccination added. Relevant history added. All concomitant medication added, Action taken updated to not applicable. Laboratory test added. Treatment drug coded.Rash updated to vaccination site rash. Fever and vaccination site redness added as new event. On 26-Jun-2021: NNI FU - No new information provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Heart rate increased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: rapid heart beat; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart beat) and PYREXIA (fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for High cholesterol.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 28-Jan-2021, the patient experienced HEART RATE INCREASED (rapid heart beat) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) 28-Jan-2021 for Fever, at a dose of 1 dosage form. On 29-Jan-2021, HEART RATE INCREASED (rapid heart beat) had resolved. At the time of the report, PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test positive: positive Positive. On 28-Jan-2021, Body temperature: 99.4 (High) high. On 29-Jan-2021, Body temperature: 99.9 (High) high.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Asthenia, COVID-19, Cough, Pain
Clinical narrative: Covid-19; weakness; Cough; aches; lost smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell). On 15-Jan-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test positive: positive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid-19; weakness; Cough; aches; lost smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell). On 15-Jan-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19), ASTHENIA (weakness), COUGH (Cough), PAIN (aches) and ANOSMIA (lost smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test positive: positive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Paraesthesia, Peripheral swelling
Clinical narrative: Chills; Fatigue; Both sides of her arm are swollen; Arms felt tingling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Both sides of her arm are swollen), PARAESTHESIA (Arms felt tingling), CHILLS (Chills) and FATIGUE (Fatigue) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (Both sides of her arm are swollen) and PARAESTHESIA (Arms felt tingling). On 23-Jan-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PERIPHERAL SWELLING (Both sides of her arm are swollen), PARAESTHESIA (Arms felt tingling), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.  Patient was due for second dose on 08 Feb 2021.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site reaction
Clinical narrative: Mosquito bite like reaction at the injection site; Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) and VACCINATION SITE REACTION (Mosquito bite like reaction at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced URTICARIA (Hives). On an unknown date, the patient experienced VACCINATION SITE REACTION (Mosquito bite like reaction at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) had resolved and VACCINATION SITE REACTION (Mosquito bite like reaction at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Patient was fine now   Most recent FOLLOW-UP information incorporated above includes: On 19-Mar-2021: Additional information received and new event Mosquito bite like reaction at the injection site was added On 19-Jun-2021: Additional information received and updated about 2 nd dose
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site warmth, Rash erythematous, Rash pruritic
Clinical narrative: Red rash at the injection site; Big rash at the injection site; Itchy rash at the injection site; Warm to the touch; A spontaneous report was received from a consumer concerning a 52-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events red rash at the injection site, big rash at the injection site, itchy rash at the injection site, warm to the touch.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 4 Feb 2021, the patient experienced the event(s) red rash at the injection site, big rash at the injection site, itchy rash at the injection site, warm to the touch.  Treatment details included Topical Benadryl cream, Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, red rash at the injection site, big rash at the injection site, itchy rash at the injection site, warm to the touch was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at injection site/COVID Arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (Rash at injection site/COVID Arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at injection site/COVID Arm). At the time of the report, VACCINATION SITE RASH (Rash at injection site/COVID Arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient developed COVID arm 10 days after first dose of vaccine.  Concomitant medication and treatment information were not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dehydration, Diarrhoea, Nausea, Vomiting
Clinical narrative: COVID-19; DEHYDRATION; Diarrhea; Nausea; Vomiting; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (COVID-19), DEHYDRATION (DEHYDRATION), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19), DEHYDRATION (DEHYDRATION), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, COVID-19 (COVID-19), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown and DEHYDRATION (DEHYDRATION) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ?No treatment information was provided. ?   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up added. New events added.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: headache; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included IBUPROFEN and PARACETAMOL (TYLENOL) for Adverse event.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea).   On 30-Jan-2021, HEADACHE (headache), PYREXIA (fever) and NAUSEA (nausea) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient had Tea with honey and cinnamon as treatment medicine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: blood sugar is loudly out of control; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar is loudly out of control) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Liver transplant in 1999. Concurrent medical conditions included Diabetic and Immunosuppression. Concomitant products included INSULIN, PARACETAMOL (TYLENOL), TACROLIMUS MONOHYDRATE (TACROLIMUS [TACROLIMUS MONOHYDRATE]) and MYCOPHENOLATE MOFETIL (MYCOPHENOLATE ACCORD) for an unknown indication.  On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Jan-2021, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar is loudly out of control). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar is loudly out of control) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Blood glucose: increased mg/dl (High) 24 hours after vaccine blood sugar rise.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment medication information were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnancy; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nasal congestion, Oropharyngeal pain, Tension headache, Vaccination site erythema
Clinical narrative: Congested; Sore throat; Tension headache; Chills; Injection site red in a big circle/round and red patch at the injection site; Soreness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat), TENSION HEADACHE (Tension headache), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol and Diabetic.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site). On 25-Jan-2021, the patient experienced NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat), TENSION HEADACHE (Tension headache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and IBUPROFEN (MOTRIN IB) for Adverse event, at a dose of UNK dosage form. In January 2021, VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site) had resolved. On 24-Jan-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. On 25-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat) and TENSION HEADACHE (Tension headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Congested; Sore throat; Tension headache; Chills; Injection site red in a big circle/round and red patch at the injection site; Soreness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat), TENSION HEADACHE (Tension headache), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol and Diabetic.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site). On 25-Jan-2021, the patient experienced NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat), TENSION HEADACHE (Tension headache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and IBUPROFEN (MOTRIN IB) for Adverse event, at a dose of UNK dosage form. In January 2021, VACCINATION SITE ERYTHEMA (Injection site red in a big circle/round and red patch at the injection site) had resolved. On 24-Jan-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. On 25-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, NASAL CONGESTION (Congested), OROPHARYNGEAL PAIN (Sore throat) and TENSION HEADACHE (Tension headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pruritus, Vaccination site erythema, Vaccination site induration
Clinical narrative: very red around the injection site; tenderness around the injection site; swelling around the injection site; warm to the touch; hardness around the injection site; her arm inside of the elbow was itchy, it looked like a mosquito bite; little bit sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (very red around the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chemotherapy on 27-Jan-2021. Concurrent medical conditions included Cancer. Concomitant products included GEMCITABINE, CARBOPLATIN, BEVACIZUMAB, METFORMIN, APIXABAN (ELIQUIS), LEVOTHYROXINE SODIUM (LEVOTHYROXIN), SIMVASTATIN, LISINOPRIL, VITAMIN B12 [VITAMIN B12 NOS] and GABAPENTIN for an unknown indication.  On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite) and MYALGIA (little bit sore arm). In January 2021, the patient experienced HEADACHE (headache). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), VACCINATION SITE ERYTHEMA (very red around the injection site), VACCINATION SITE PAIN (tenderness around the injection site) and VACCINATION SITE SWELLING (swelling around the injection site). On 14-Jan-2021, PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite) and MYALGIA (little bit sore arm) had resolved.   At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), HEADACHE (headache), VACCINATION SITE ERYTHEMA (very red around the injection site), VACCINATION SITE PAIN (tenderness around the injection site) and VACCINATION SITE SWELLING (swelling around the injection site) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The patient did not receive any treatment. No treatment medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: very red around the injection site; tenderness around the injection site; swelling around the injection site; warm to the touch; hardness around the injection site; her arm inside of the elbow was itchy, it looked like a mosquito bite; little bit sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (very red around the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chemotherapy on 27-Jan-2021. Concurrent medical conditions included Cancer. Concomitant products included GEMCITABINE, CARBOPLATIN, BEVACIZUMAB, METFORMIN, APIXABAN (ELIQUIS), LEVOTHYROXINE SODIUM (LEVOTHYROXIN), SIMVASTATIN, LISINOPRIL, VITAMIN B12 [VITAMIN B12 NOS] and GABAPENTIN for an unknown indication.  On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite) and MYALGIA (little bit sore arm). In January 2021, the patient experienced HEADACHE (headache). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), VACCINATION SITE ERYTHEMA (very red around the injection site), VACCINATION SITE PAIN (tenderness around the injection site) and VACCINATION SITE SWELLING (swelling around the injection site). On 14-Jan-2021, PRURITUS (her arm inside of the elbow was itchy, it looked like a mosquito bite) and MYALGIA (little bit sore arm) had resolved.   At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE INDURATION (hardness around the injection site), HEADACHE (headache), VACCINATION SITE ERYTHEMA (very red around the injection site), VACCINATION SITE PAIN (tenderness around the injection site) and VACCINATION SITE SWELLING (swelling around the injection site) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The patient did not receive any treatment. No treatment medications were reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Vaccination site erythema, Vaccination site pain
Clinical narrative: Warm to touch at injection site; Felt like didnt enjoy living in my skin; Itchy at injection site; Chills; Tired; Injection site is very very red; Sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills) and FATIGUE (Tired) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included POTASSIUM for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills), FATIGUE (Tired), VACCINATION SITE ERYTHEMA (Injection site is very very red) and VACCINATION SITE PAIN (Sore at injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills), FATIGUE (Tired), VACCINATION SITE ERYTHEMA (Injection site is very very red) and VACCINATION SITE PAIN (Sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received on 16 APR 2021and does not contain any new information
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to touch at injection site; Felt like didnt enjoy living in my skin; Itchy at injection site; Chills; Tired; Injection site is very very red; Sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills) and FATIGUE (Tired) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included POTASSIUM for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills), FATIGUE (Tired), VACCINATION SITE ERYTHEMA (Injection site is very very red) and VACCINATION SITE PAIN (Sore at injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at injection site), FEELING ABNORMAL (Felt like didnt enjoy living in my skin), VACCINATION SITE PRURITUS (Itchy at injection site), CHILLS (Chills), FATIGUE (Tired), VACCINATION SITE ERYTHEMA (Injection site is very very red) and VACCINATION SITE PAIN (Sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received on 16 APR 2021and does not contain any new information
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive Patient received vaccine and tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dizziness, Heart rate increased, Influenza like illness
Clinical narrative: COVID-19; flu-like symptoms; kind of weak; little bit dizzy; fast heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heart rate), INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (kind of weak), DIZZINESS (little bit dizzy) and COVID-19 (COVID-19) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0371C20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced HEART RATE INCREASED (fast heart rate), ASTHENIA (kind of weak) and DIZZINESS (little bit dizzy). On 31-Dec-2020, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). On 06-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, HEART RATE INCREASED (fast heart rate), ASTHENIA (kind of weak) and DIZZINESS (little bit dizzy) had resolved, INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown and COVID-19 (COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, SARS-CoV-2 test: (Positive) positive. On 25-Jan-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received on 16-APR-2021 and Added reporter's email address
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: COVID-19; flu-like symptoms; kind of weak; little bit dizzy; fast heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heart rate), INFLUENZA LIKE ILLNESS (flu-like symptoms), ASTHENIA (kind of weak), DIZZINESS (little bit dizzy) and COVID-19 (COVID-19) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0371C20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced HEART RATE INCREASED (fast heart rate), ASTHENIA (kind of weak) and DIZZINESS (little bit dizzy). On 31-Dec-2020, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). On 06-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, HEART RATE INCREASED (fast heart rate), ASTHENIA (kind of weak) and DIZZINESS (little bit dizzy) had resolved, INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown and COVID-19 (COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, SARS-CoV-2 test: (Positive) positive. On 25-Jan-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received on 16-APR-2021 and Added reporter's email address
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: experience rash on the arm; experience  itchiness on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (experience rash on the arm) and VACCINATION SITE PRURITUS (experience  itchiness on the arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (experience rash on the arm) and VACCINATION SITE PRURITUS (experience  itchiness on the arm). The patient was treated with CORTISONE at a dose of unknown. At the time of the report, VACCINATION SITE RASH (experience rash on the arm) and VACCINATION SITE PRURITUS (experience  itchiness on the arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: red swelling rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red swelling rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (red swelling rash). At the time of the report, RASH ERYTHEMATOUS (red swelling rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment information included after bite cream.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Weird reaction after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Weird reaction after receiving vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Weird reaction after receiving vaccine). At the time of the report, VACCINATION COMPLICATION (Weird reaction after receiving vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dehydration, Dyspnoea, Limb discomfort, Migraine
Clinical narrative: Dehydration; Soreness in arm; Discomfort in arm; High temperature; nausea; shakes; Difficulty breathing through nose; Svere headaches similar to a migraine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), DEHYDRATION (Dehydration), PAIN IN EXTREMITY (Soreness in arm) and LIMB DISCOMFORT (Discomfort in arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), PAIN IN EXTREMITY (Soreness in arm), LIMB DISCOMFORT (Discomfort in arm), PYREXIA (High temperature), NAUSEA (nausea) and TREMOR (shakes). On 18-Jan-2021, the patient experienced DEHYDRATION (Dehydration). At the time of the report, DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), DEHYDRATION (Dehydration), PAIN IN EXTREMITY (Soreness in arm), LIMB DISCOMFORT (Discomfort in arm), PYREXIA (High temperature), NAUSEA (nausea) and TREMOR (shakes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Body temperature: (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by reporter. Treatment medications used were unknown and not provided by reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Tremor
Clinical narrative: Dehydration; Soreness in arm; Discomfort in arm; High temperature; nausea; shakes; Difficulty breathing through nose; Svere headaches similar to a migraine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), DEHYDRATION (Dehydration), PAIN IN EXTREMITY (Soreness in arm) and LIMB DISCOMFORT (Discomfort in arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), PAIN IN EXTREMITY (Soreness in arm), LIMB DISCOMFORT (Discomfort in arm), PYREXIA (High temperature), NAUSEA (nausea) and TREMOR (shakes). On 18-Jan-2021, the patient experienced DEHYDRATION (Dehydration). At the time of the report, DYSPNOEA (Difficulty breathing through nose), MIGRAINE (Svere headaches similar to a migraine), DEHYDRATION (Dehydration), PAIN IN EXTREMITY (Soreness in arm), LIMB DISCOMFORT (Discomfort in arm), PYREXIA (High temperature), NAUSEA (nausea) and TREMOR (shakes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Body temperature: (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by reporter. Treatment medications used were unknown and not provided by reporter.